- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
Anonymous complaint alleged industry-funded audits/workshops and coercive behaviour linked to prescribing. Panel found no evidence against Sanofi; its MEGS nurse advisor service…
PMCPA found Roche failed to disclose results of a Phase Ib/IIa trial (BP22572) within required timelines due to internal phase misclassification. Breach…
Pulse online ad and emails invited HCPs to a Pfizer-funded stop smoking roadshow. Panel found sponsorship clear and no PI required on…
A hospital pharmacist challenged a Remicade journal ad using a dandelion image and the strapline “more than a name”. Appeal Board found…
An Otsuka employee used a personal LinkedIn account to share links about tolvaptan and brexpiprazole. The Panel found promotion of POMs to…
Anonymous complaint about allegedly inappropriate Medikinet mailings, rep calls, and a German clinical paper. Panel found targeting to child psychiatrists/paediatricians reasonable and…
A hospital pharmacist complained an Abbott rep asked her to increase Kaletra orders so he could get a Christmas bonus. PMCPA ruled…
At a Teva-sponsored asthma meeting, the Panel said the medical director’s talk was promotional and misleading for omitting that Qvar wasn’t licensed…
Anonymous alleged pharma-funded conference hospitality was inappropriate. Panel found Wyeth had not agreed to sponsor the 2007 meeting, so there could be…
Altana’s Protium materials compared to Nexium used “equivalent/comparable” healing and symptom claims and “2 days faster” messaging. PMCPA found misleading, unsubstantiated comparisons…
Novartis reported that an Exforge (amlodipine/valsartan) advertisement ran in UK medical press before UK marketing authorisation. PMCPA found breaches of Clauses 3.1…
A PCT pharmacist alleged a Champix budget-impact presentation to a stop smoking service was impermissible advance notification. Panel found Champix already had…
Servier admitted a rep used unsolicited promotional email and self-created promotional letters about Protelos without certification or prescribing info. PMCPA found breaches…
A rep provided GP practice spreadsheets comparing antihypertensives and showing “profit per script”. Panel said they went beyond an enquiry response, were…
PMCPA case AUTH/2999/12/17 (Director v Otsuka) about clinical trial disclosure for Deltyba. Outcome: no breach; matter found outwith the scope of the…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.